Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the Elderly.

MLA

McCormick, Thomas A., et al. “Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the Elderly.” EGEMS (Washington, DC), vol. 7, no. 1, Aug. 2019, p. 46. EBSCOhost, https://doi.org/10.5334/egems.303.

APA

McCormick, T. A., Adams, J. L., Lee, E. A., Emptage, N. P., Palmer-Toy, D. E., Martin, J. P., Broder, B. I., Kanter, M. H., Davis, A. C., & McGlynn, E. A. (2019). Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the Elderly. EGEMS (Washington, DC), 7(1), 46. https://doi.org/10.5334/egems.303

Chicago

McCormick, Thomas A, John L Adams, Eric A Lee, Nicholas P Emptage, Darryl E Palmer-Toy, John P Martin, Benjamin I Broder, Michael H Kanter, Anna C Davis, and Elizabeth A McGlynn. 2019. “Age-Dependent Hemoglobin A1c Therapeutic Targets Reduce Diabetic Medication Changes in the Elderly.” EGEMS (Washington, DC) 7 (1): 46. doi:10.5334/egems.303.